Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Joseph

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
European Journal of Heart Failure|November 25, 2024
Heart failure after left atrial appendage occlusion: Insights from the LAAOS III randomized trialPhilipp Krisai, Emilie P Belley-Cote, William F McIntyre, et al.
Lancet Regional Health. Americas|April 2, 2025
Prediction of cardiovascular risk: validation of a non-laboratory and a laboratory-based score in a Brazilian community-based cohort of the PURE studyGustavo Bernardes de Figueiredo Oliveira, Rafael Amorim Belo Nunes, Lucas Bassolli de Oliveira Alves, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 28, 2020
Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysisMariëlle Kloosterman, Jonas Oldgren, David Conen, et al.
Lancet (London, England)|September 1, 2021
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysisPhilip Joseph, Gholamreza Roshandel, Peggy Gao, et al.
ESC Heart Failure|May 13, 2026
FEV1 is a major prognostic factor in diverse Heart Failure populations: findings from a Global Heart Failure registryMyLinh Duong, Shofiqul Islam, Philip Joseph, et al.
JACC. Heart Failure|October 30, 2025
Diet and Clinical Outcomes in a Heart Failure PopulationPhilip Joseph, Mahshid Dehghan, Justin A Ezekowitz, et al.
The Lancet. Global Health|September 24, 2020
Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trialRuanne V Barnabas, Adam A Szpiro, Heidi van Rooyen, et al.
Infectious Diseases and Therapy|April 16, 2023
Clinical and Genomic Evolution of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections over Two Time Periods at a Tertiary Care Hospital in South India: A Prospective Cohort StudyAbi Manesh, Chaitra Shankar, Mithun M George, et al.
Heart (British Cardiac Society)|October 26, 2017
Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the worldPhilip Joseph, Salim Yusuf, Shun Fu Lee, et al.
European Heart Journal|May 8, 2021
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participantsJackie Bosch, Eva M Lonn, Hyejung Jung, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
European Journal of Heart Failure|November 25, 2024
Heart failure after left atrial appendage occlusion: Insights from the LAAOS III randomized trialPhilipp Krisai, Emilie P Belley-Cote, William F McIntyre, et al.
Lancet Regional Health. Americas|April 2, 2025
Prediction of cardiovascular risk: validation of a non-laboratory and a laboratory-based score in a Brazilian community-based cohort of the PURE studyGustavo Bernardes de Figueiredo Oliveira, Rafael Amorim Belo Nunes, Lucas Bassolli de Oliveira Alves, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 28, 2020
Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysisMariëlle Kloosterman, Jonas Oldgren, David Conen, et al.
Lancet (London, England)|September 1, 2021
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysisPhilip Joseph, Gholamreza Roshandel, Peggy Gao, et al.
ESC Heart Failure|May 13, 2026
FEV1 is a major prognostic factor in diverse Heart Failure populations: findings from a Global Heart Failure registryMyLinh Duong, Shofiqul Islam, Philip Joseph, et al.
JACC. Heart Failure|October 30, 2025
Diet and Clinical Outcomes in a Heart Failure PopulationPhilip Joseph, Mahshid Dehghan, Justin A Ezekowitz, et al.
The Lancet. Global Health|September 24, 2020
Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trialRuanne V Barnabas, Adam A Szpiro, Heidi van Rooyen, et al.
Infectious Diseases and Therapy|April 16, 2023
Clinical and Genomic Evolution of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections over Two Time Periods at a Tertiary Care Hospital in South India: A Prospective Cohort StudyAbi Manesh, Chaitra Shankar, Mithun M George, et al.
Heart (British Cardiac Society)|October 26, 2017
Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the worldPhilip Joseph, Salim Yusuf, Shun Fu Lee, et al.
European Heart Journal|May 8, 2021
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participantsJackie Bosch, Eva M Lonn, Hyejung Jung, et al.
Pageof 11